Upstate Active Clinical Trials
Study Title:ADC-042-PRAZ: Prazosin for Disruptive Agitation in Alzheimer’s Disease (AD) (PEACE-AD)
What is the purpose of the study?The purpose of this research is to see if a drug called prazosin can help make agitation symptoms such as irritability, anger outbursts, and pacing better for patients with Alzheimer’s disease.
Upstate Institutional Review Board (IRB) Number:1689413
Study/Protocol ID:ADC-042-PRAZ (PEACE-AD)
Study Phase:Phase 2b
Patient Age Group:Adults
Principal Investigator:Sharon A Brangman
What is involved if I participate?
- How long is the study?
- Is transportation provided or reimbursed?
- Is parking provided or reimbursed?
- What tests and procedures are involved?
Blood tests, ECG, vitals, behavioral assessment, activities of daily living assessment
Where will the study take place?Institute for Human Performance. Remote visits also available.
Other Information:Study partner required
Who can I contact for more information?
Name: Megan Schuler